← Leaderboards
Charles F Eisenbeis
Ohio State University
$471,504
Attributed
$471,504
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$471,504 · 1
By mechanism
K08$471,504 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Michael A Caligiuri$65,062,344
- Robert Alan Baiocchi$3,789,234
- Rosa Lapalombella$5,349,017
- Yang Liu$21,443,530
- Maria-Eugenia Ariza$2,718,319
Others in their field
Top investigators on “B Cell Lymphoma”
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Robert B. Diasio · University Of Alabama At Birmingham$28,625,297
- Shannon Celeste Kenney · University Of North Carolina Chapel Hill$24,162,169
- Ari M. Melnick · Mount Sinai School Of Medicine Of Nyu$23,742,656
- Scott W Wong · Oregon Health And Science University$22,837,332
- David Heimbrook · Leidos Biomedical Research, Inc.$22,104,083
Research focus
B Cell LymphomaEnzyme Linked Immunosorbent AssayMonoclonal AntibodyNeoplasm /Cancer ImmunologyCytotoxic T LymphocyteScid MouseTissue /Cell CultureDosageAntibody ReceptorFlow CytometryHuman TissueImmunopharmacologyImmunotherapyInterleukin 2Polymerase Chain ReactionEpstein Barr VirusAntineoplasticsApoptosisCell Mediated CytotoxicityCell Mediated Lymphocytolysis TestClinical ResearchComplement
Grant awards (4)
Daily Low-Dose IL-2 Augments Anti-CD20 Antibody Therapy$134,784
K08 · FY2005 · CA
Daily Low-Dose IL-2 Augments Anti-CD20 Antibody Therapy$134,784
K08 · FY2004 · CA
Daily Low-Dose IL-2 Augments Anti-CD20 Antibody Therapy$134,784
K08 · FY2003 · CA
Daily Low-Dose IL-2 Augments Anti-CD20 Antibody Therapy$67,152
K08 · FY2002 · CA